Cover Image
市場調查報告書

手術用人工血管:醫療設備的開發平台評估

Vascular Grafts - Medical Devices Pipeline Assessment, 2015

出版商 GlobalData 商品編碼 346859
出版日期 內容資訊 英文 49 Pages
訂單完成後即時交付
價格
Back to Top
手術用人工血管:醫療設備的開發平台評估 Vascular Grafts - Medical Devices Pipeline Assessment, 2015
出版日期: 2015年12月01日 內容資訊: 英文 49 Pages
簡介

本報告提供手術用人工血管的開發中產品調查分析,以各開發階段比較分析為焦點,提供開發中產品的開發中主要企業,進行中的臨床試驗相關資訊等系統性資訊。

第1章 目錄

第2章 簡介

  • 手術用人工血管概要

第3章 開發中的產品

  • 手術用人工血管 - 開發中產品:各開發階段
  • 手術用人工血管 - 開發中產品:各地區
  • 手術用人工血管 - 開發中產品:各法規
  • 手術用人工血管 - 開發中產品:各核准預定日
  • 手術用人工血管 - 進行中的臨床試驗

第4章 手術用人工血管 - 正在開發的開發中產品:各企業

  • 手術用人工血管企業 - 開發中產品:各開發階段
  • 手術用人工血管 - 開發中產品:各開發階段

第5章 手術用人工血管企業與產品概要

  • 3S BioMedical, Inc.
  • Anethon (Inactive)
  • ARISTE Medical
  • Cardiojustable LLC
  • CryoLife, Inc.
  • DSM Biomedical B.V.
  • Eqalix, Inc.
  • FIT Biotech Oy
  • Gel-Del Technologies, Inc.
  • Graftworx, LLC
  • Healionics Corporation
  • Innovia LLC
  • MultiGene Vascular Systems (MGVS) Ltd.
  • NuVascular Technologies Inc
  • Sree Chitra Tirunal Institute for Medical Sciences & Technology
  • SurgaColl Technologies Ltd
  • Universidad de Los Andes
  • VesselTek BioMedical LLC
  • Xeltis AG

第6章 手術用人工血管 - 最近的趨勢

第7章 附錄

圖表

目錄
Product Code: GDME0109EPD

GlobalData's Medical Devices sector report, "Vascular Grafts - Medical Devices Pipeline Assessment, 2015" provides an overview of Vascular Grafts currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Vascular Grafts pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Vascular Grafts under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Vascular Grafts and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry

Reasons to buy

The report enables you to -

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Vascular Grafts under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product's current stage of development, territory and estimated launch date

Table of Contents

1. Table of Contents

  • 1.1. List of Tables
  • 1.2. List of Figures

2. Introduction

  • 2.1. Vascular Grafts Overview

3. Products under Development

  • 3.1. Vascular Grafts - Pipeline Products by Stage of Development
  • 3.2. Vascular Grafts - Pipeline Products by Territory
  • 3.3. Vascular Grafts - Pipeline Products by Regulatory Path
  • 3.4. Vascular Grafts - Pipeline Products by Estimated Approval Date
  • 3.5. Vascular Grafts - Ongoing Clinical Trials

4. Vascular Grafts - Pipeline Products under Development by Companies

  • 4.1. Vascular Grafts Companies - Pipeline Products by Stage of Development
  • 4.2. Vascular Grafts - Pipeline Products by Stage of Development

5. Vascular Grafts Companies and Product Overview

  • 5.1. 3S BioMedical, Inc. Company Overview
    • 5.1.1. 3S BioMedical, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.2. Anethon (Inactive) Company Overview
    • 5.2.1. Anethon (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
  • 5.3. ARISTE Medical Company Overview
    • 5.3.1. ARISTE Medical Pipeline Products & Ongoing Clinical Trials Overview
  • 5.4. Cardiojustable LLC Company Overview
    • 5.4.1. Cardiojustable LLC Pipeline Products & Ongoing Clinical Trials Overview
  • 5.5. CryoLife, Inc. Company Overview
    • 5.5.1. CryoLife, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.6. DSM Biomedical B.V. Company Overview
    • 5.6.1. DSM Biomedical B.V. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.7. Eqalix, Inc. Company Overview
    • 5.7.1. Eqalix, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.8. FIT Biotech Oy Company Overview
    • 5.8.1. FIT Biotech Oy Pipeline Products & Ongoing Clinical Trials Overview
  • 5.9. Gel-Del Technologies, Inc. Company Overview
    • 5.9.1. Gel-Del Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.10. Graftworx, LLC Company Overview
    • 5.10.1. Graftworx, LLC Pipeline Products & Ongoing Clinical Trials Overview
  • 5.11. Healionics Corporation Company Overview
    • 5.11.1. Healionics Corporation Pipeline Products & Ongoing Clinical Trials Overview
  • 5.12. Innovia LLC Company Overview
    • 5.12.1. Innovia LLC Pipeline Products & Ongoing Clinical Trials Overview
  • 5.13. MultiGene Vascular Systems (MGVS) Ltd. Company Overview
    • 5.13.1. MultiGene Vascular Systems (MGVS) Ltd. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.14. NuVascular Technologies Inc Company Overview
    • 5.14.1. NuVascular Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview
  • 5.15. Sree Chitra Tirunal Institute for Medical Sciences & Technology Company Overview
    • 5.15.1. Sree Chitra Tirunal Institute for Medical Sciences & Technology Pipeline Products & Ongoing Clinical Trials Overview
  • 5.16. SurgaColl Technologies Ltd Company Overview
    • 5.16.1. SurgaColl Technologies Ltd Pipeline Products & Ongoing Clinical Trials Overview
  • 5.17. Universidad de Los Andes Company Overview
    • 5.17.1. Universidad de Los Andes Pipeline Products & Ongoing Clinical Trials Overview
  • 5.18. VesselTek BioMedical LLC Company Overview
    • 5.18.1. VesselTek BioMedical LLC Pipeline Products & Ongoing Clinical Trials Overview
  • 5.19. Xeltis AG Company Overview
    • 5.19.1. Xeltis AG Pipeline Products & Ongoing Clinical Trials Overview

6. Vascular Grafts- Recent Developments

7. Appendix

  • 7.1. Methodology
  • 7.2. About GlobalData
  • 7.3. Contact Us
  • 7.4. Disclaimer

List of Tables

  • Table 1: Vascular Grafts - Pipeline Products by Stage of Development
  • Table 2: Vascular Grafts - Pipeline Products by Territory
  • Table 3: Vascular Grafts - Pipeline Products by Regulatory Path
  • Table 4: Vascular Grafts - Pipeline Products by Estimated Approval Date
  • Table 5: Vascular Grafts - Ongoing Clinical Trials
  • Table 6: Vascular Grafts Companies - Pipeline Products by Stage of Development
  • Table 7: Vascular Grafts - Pipeline Products by Stage of Development
  • Table 8: 3S BioMedical, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 9: Resorpor AdvaMatrix Micro Small Vessel Graft - Product Status
  • Table 10: Resorpor AdvaMatrix Micro Small Vessel Graft - Product Description
  • Table 11: Resorpor AdvaMatrixrPro Vessel Graft - Product Status
  • Table 12: Resorpor AdvaMatrixrPro Vessel Graft - Product Description
  • Table 13: Anethon (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
  • Table 14: Anethon Blood Vessel - Product Status
  • Table 15: Anethon Blood Vessel - Product Description
  • Table 16: ARISTE Medical Pipeline Products & Ongoing Clinical Trials Overview
  • Table 17: Drug Eluting Vascular Graft - Product Status
  • Table 18: Drug Eluting Vascular Graft - Product Description
  • Table 19: Cardiojustable LLC Pipeline Products & Ongoing Clinical Trials Overview
  • Table 20: Adjustable Vascular Graft - Product Status
  • Table 21: Adjustable Vascular Graft - Product Description
  • Table 22: CryoLife, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 23: Synergraft Xenograft Vascular Graft - Product Status
  • Table 24: Synergraft Xenograft Vascular Graft - Product Description
  • Table 25: DSM Biomedical B.V. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 26: Small Diameter Vascular Graft - Product Status
  • Table 27: Small Diameter Vascular Graft - Product Description
  • Table 28: Eqalix, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 29: CardioVessel - Product Status
  • Table 30: CardioVessel - Product Description
  • Table 31: LCL Graft - Product Status
  • Table 32: LCL Graft - Product Description
  • Table 33: FIT Biotech Oy Pipeline Products & Ongoing Clinical Trials Overview
  • Table 34: GTU X-Graft - Product Status
  • Table 35: GTU X-Graft - Product Description
  • Table 36: GTU X2-Graft - Product Status
  • Table 37: GTU X2-Graft - Product Description
  • Table 38: Gel-Del Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 39: VasoGraft - Product Status
  • Table 40: VasoGraft - Product Description
  • Table 41: Graftworx, LLC Pipeline Products & Ongoing Clinical Trials Overview
  • Table 42: Smart Graft - Product Status
  • Table 43: Smart Graft - Product Description
  • Table 44: Healionics Corporation Pipeline Products & Ongoing Clinical Trials Overview
  • Table 45: STARgraft - Vascular Reconstruction - Product Status
  • Table 46: STARgraft - Vascular Reconstruction - Product Description
  • Table 47: Innovia LLC Pipeline Products & Ongoing Clinical Trials Overview
  • Table 48: 4mm Vascular Graft - Product Status
  • Table 49: 4mm Vascular Graft - Product Description
  • Table 50: MultiGene Vascular Systems (MGVS) Ltd. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 51: MultiGeneGraft - Product Status
  • Table 52: MultiGeneGraft - Product Description
  • Table 53: NuVascular Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview
  • Table 54: BioFunc - APC Vascular Graft - Product Status
  • Table 55: BioFunc - APC Vascular Graft - Product Description
  • Table 56: Sree Chitra Tirunal Institute for Medical Sciences & Technology Pipeline Products & Ongoing Clinical Trials Overview
  • Table 57: Enhanced Vascular Graft - Product Status
  • Table 58: Enhanced Vascular Graft - Product Description
  • Table 59: SurgaColl Technologies Ltd Pipeline Products & Ongoing Clinical Trials Overview
  • Table 60: CardioColl - Product Status
  • Table 61: CardioColl - Product Description
  • Table 62: Universidad de Los Andes Pipeline Products & Ongoing Clinical Trials Overview
  • Table 63: SiSgraft - Product Status
  • Table 64: SiSgraft - Product Description
  • Table 65: VesselTek BioMedical LLC Pipeline Products & Ongoing Clinical Trials Overview
  • Table 66: VTek Graft - Product Status
  • Table 67: VTek Graft - Product Description
  • Table 68: VTek-RA Graft - Product Status
  • Table 69: VTek-RA Graft - Product Description
  • Table 70: VTek-RA Wrap - Product Status
  • Table 71: VTek-RA Wrap - Product Description
  • Table 72: Xeltis AG Pipeline Products & Ongoing Clinical Trials Overview
  • Table 73: Endogenous Tissue Growth Implant - Product Status
  • Table 74: Endogenous Tissue Growth Implant - Product Description
  • Table 75: Xeltis AG - Ongoing Clinical Trials Overview
  • Table 76: Endogenous Tissue Growth Implant - Initial Safety and Performance of the COR-VP-001 Vascular Patch in Pediatric Patients Undergoing the Right Ventricular Outflow Tract (RVOT) Reconstruction
  • Table 77: Glossary

List of Figures

  • Figure 1: Vascular Grafts - Pipeline Products by Stage of Development
  • Figure 2: Vascular Grafts - Pipeline Products by Territory
  • Figure 3: Vascular Grafts - Pipeline Products by Regulatory Path
  • Figure 4: Vascular Grafts - Pipeline Products by Estimated Approval Date
  • Figure 5: Vascular Grafts - Ongoing Clinical Trials
Back to Top